About
Research
Patient Care
Education
Community
Jun 26, 2024 | UCI School of Physical Sciences
Professor Gregory Weiss Awarded UC Irvine Anti-Cancer Challenge Funding
The Weiss Lab studies the biochemistry of the molecules that make life function, and the new funding will support research into molecules called enzymes that play a key role in the spread of cancer cells in the human body. Weiss plans to work with colleagues in the UC Irvine Chao Family Comprehensive Cancer Center Cancer Control program to create a plan to connect with members of the AAPI community who are willing to be a part of the lab’s research.
Jun 17, 2024 | UCI Public Health
UC Irvine joins a national network of partners to address cancer, the leading cause of death, among Asian Americans
Asian Americans have become the first racial/ethnic group for whom cancer is the leading cause of death. Yet, Asian Americans are often underrepresented in clinical trials and cancer research. To address this, the NCI has awarded $12.45 million to create a national cohort called ASPIRE.
May 31, 2024
A literal gut check
A healthy microbiome in your digestive tract can help stave off heart disease, cancer and other ailments, says Katrine Whiteson, a Chancellor’s Fellow and associate professor of molecular biology and biochemistry at UC Irvine.
May 13, 2024
Dr. Aryana Sepassi, Dr. Alexandre Chan, and Team Publish Findings on “Rural-Urban Disparities in Colorectal Cancer Screening, Diagnosis, Treatment, and Survivorship Care”
In a study published in The Oncologist, Dr. Aryana Sepassi, Dr. Alexandre Chan, and their fellow researchers shared their findings regarding colorectal cancer concerns among rural residents, as compared to people living in urban settings.
May 03, 2024
Dr. Alexandre Chan Recognized with Helen McKinnon Award from International Society of Oncology Pharmacy Practitioners (ISOPP)
The Helen McKinnon Award, named after a founding member of ISOPP, recognizes people who have significantly contributed to the group and the profession of oncology pharmacy at large.
Apr 10, 2024
Dr. Alexandre Chan Given Basic and Clinical Research Literature Award from Hematology/Oncology Pharmacy Association (HOPA)
Dr. Alexandre Chan, Founding Chair of the Department of Clinical Pharmacy Practice in the UC Irvine School of Pharmacy & Pharmaceutical Sciences, has been selected by the Hematology/Oncology Pharmacy Association (HOPA) as the recipient of their Basic and Clinical Research Literature Award!
Apr 08, 2024
Dr. Shawn Griffin Received Volunteer Award from Hematology/Oncology Pharmacy Association (HOPA)
Dr. Shawn Griffin, health sciences assistant clinical professor in the UC Irvine School of Pharmacy & Pharmaceutical Sciences, was honored by the Hematology/Oncology Pharmacy Association (HOPA) with their Volunteer Award!
Feb 27, 2024
National Cancer Prevention Month with Dr. Alexandre Chan, Dr. Shawn Griffin, and Dr. Mahtab Jafari
Dr. Alexandre Chan, Dr. Shawn Griffin, and Dr. Mahtab Jafari are three of the many faculty members in the UC Irvine School of Pharmacy & Pharmaceutical Sciences who advance the field of cancer research and work with patients to help minimize their risk for cancer, as well as help to prevent further health issues in people who are currently fighting cancer or are cancer survivors.
Feb 21, 2024
UC Irvine co-led study that uses artificial intelligence to identify unwanted variations in blood samples by 95%
A new study led by co-corresponding authors, Min Zhang, MD, PhD, and Dabao Zhang, PhD, professors of epidemiology and biostatistics at the University of California, Irvine’s Program in Public Health, used artificial intelligence (AI) to analyze ‘big data’ sets of biological samples to reduce unwanted variations by more than 95%.
Feb 12, 2024
Dr. Alexandre Chan Appointed as Vice Chair of Board of Pharmacy Specialties’ Oncology Pharmacy Specialty Council
BPS is a group that is responsible for establishing standards related to the training and certification of pharmacists. Within the organization, there are multiple specialty councils that focus on specific aspects of pharmacy care. “As part of the Oncology Pharmacy Specialty Council, I am involved with the development of the board certification examination to ensure that we provide a consistent experience and high-quality examination development outcomes,” he explained.